DRUG · Unmapped registry intervention
Active Investigational Treatment ENT-01
Find medicine records ·
Find other trials using this name
Clinical trial
Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety "Roll-over" Study (Rollover)
NCT04483479
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedOrally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety "Roll-over" Study (Rollover)
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Parkinson Diseaseverified · MONDO: Parkinson disease
Constipationverified · MONDO: constipation disorder
Interventions
Sponsors & collaborators
Enterin Inc.lead sponsor
Mapped research locations
New YorkNew York, United States1ClevelandOhio, United States1TampaFlorida, United States1Washington D.C.District of Columbia, United States1AlbanyNew York, United States1West Palm BeachFlorida, United States1ToledoOhio, United States1SarasotaFlorida, United States1LebanonNew Hampshire, United States1Boca RatonFlorida, United States1HersheyPennsylvania, United States1PasadenaCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04483479 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.